NCT04895059View on ClinicalTrials.gov

Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2017

Primary Completion Date

January 15, 2018

Study Completion Date

January 22, 2018

Conditions

Healthy

Interventions

DRUG

Rosuvastatin (20mg) /Ezetimibe (10mg) in fixed dose

Form: Tablets Dosage: 20 mg Adminstration way: Oral

DRUG

Rosuvastatin 20mg

Pharmaceutical Form: Tablets Dosage: 20 mg Adminstration way: Oral

DRUG

Ezetimibe 10mg

Pharmaceutical Form: Tablets Dosage: 10 mg Adminstration way: Oral

Trial Locations (1)

11000

Laboratorio Silanes, S.A. de C.V., Mexico City

All Listed Sponsors

lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY

NCT04895059 - Study of no Pharmacokinetic Interaction Between Rosuvastatin 20mg and Ezetimibe10mg, Fixed Dose vs Individual Components | Biotech Hunter | Biotech Hunter